pentobarbital will decrease the extent or effect of linagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use of other treatments is strongly recommended when linagliptin will be to be administered which has a CYP3A4 inducerpentobarbital will decrease the extent or outcome of fosaprepitant by impacting hepatic/i